Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00822315
What this trial is testing

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
ANRS, Emerging Infectious Diseases 155
Post-approval studies (Phase 4)Ended earlyNCT00122668
What this trial is testing

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 112
Not applicableStudy completedNCT00029913
What this trial is testing

Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials

Who this might be right for
HIV Infections
HIV Vaccine Trials Network 54
Early research (Phase 1)Study completedNCT00004579
What this trial is testing

See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

Who this might be right for
HIV InfectionsHIV Seronegativity
Walter Reed Army Institute of Research (WRAIR)
Testing effectiveness (Phase 2)Ended earlyNCT00090779
What this trial is testing

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 130
Early research (Phase 1)Study completedNCT02018510
What this trial is testing

A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117

Who this might be right for
HealthyHIV
Rockefeller University 49
Not applicableStudy completedNCT06285110
What this trial is testing

HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based Regimen

Who this might be right for
Hiv
University of Bern 1,103
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Not applicableStudy completedNCT04596488
What this trial is testing

Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients

Who this might be right for
HIV-1-infection
Peking Union Medical College Hospital 25
Large-scale testing (Phase 3)Study completedNCT00046176
What this trial is testing

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 240
Early research (Phase 1)WithdrawnNCT04041674
What this trial is testing

Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult Participants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT01227824
What this trial is testing

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 828
Testing effectiveness (Phase 2)Study completedNCT02175680
What this trial is testing

Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection

Who this might be right for
HIVHuman Immunodeficiency Virus
CytoDyn, Inc. 43
Testing effectiveness (Phase 2)Looking for participantsNCT04648046
What this trial is testing

CAR-T Cells for HIV Infection

Who this might be right for
HIV Infections
Steven Deeks 18
Testing effectiveness (Phase 2)UnknownNCT03869944
What this trial is testing

Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV

Who this might be right for
HIV-1
ANRS, Emerging Infectious Diseases 97
Very early researchStudy completedNCT06541093
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.

Who this might be right for
AIDS/HIV - RelatedDisease Associated With AIDSVaccine-Preventable DiseasesHIV Infections
Uvax Bio LLC 34
Large-scale testing (Phase 3)Study completedNCT00146328
What this trial is testing

Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects

Who this might be right for
HIV Infections
Boehringer Ingelheim 997
Not applicableStudy completedNCT01980771
What this trial is testing

Barbershop Talk: HIV Prevention for African American Heterosexual Men

Who this might be right for
HIV
State University of New York - Downstate Medical Center 860
Post-approval studies (Phase 4)Ended earlyNCT02322099
What this trial is testing

Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

Who this might be right for
Bone Demineralization
University College Dublin 53
Early research (Phase 1)UnknownNCT03199690
What this trial is testing

A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers

Who this might be right for
HIV-1-infectionTuberculosis
St. Stephens Clinical Research 16
Next Page